FDA granted market authorization for a non-invasive, smartphone device that offers respite from migraines.
FDA cleared alpelisib (Piqray), the first PI3K inhibitor to treat breast cancer, to be used in combination with fulvestrant (Faslodex).
Express Scripts, a Cigna company, plans to launch the industry's first stand-alone digital health formulary.
FDA approved some important new therapies, including the first anticoagulant for children, an injectable for diabetic retinopathy, and a treatment for renal cell carcinoma.
Generic drug makers are defending their practices after 44 US states accused Teva Pharmaceuticals and other pharma makers of conspiring to inflate their prices in a lawsuit.
A new government rule requiring pharma makers to disclose drug prices in television ads will likely create more confusion for consumers, analysts and organizations said.
While FDA approved the second biosimilar drug to Enbrel, the success of the medication hinges on a pending lawsuit.
Stronger warnings on popular insomnia medications could have an impact on prescribing, some experts say.
CDC commentary claims patients taken off opiods too soon.
A new report determines the trends fueling drug research and development over the past 10 years—and into the future.